STEM-CELL RESPONSES IN MYELOSUPPRESSED MICE FOLLOWING SEQUENTIAL TREATMENT WITH RECOMBINANT HUMAN INTERLEUKIN-1 (RHUIL-1), RECOMBINANT MURINE INTERLEUKIN-3 (RMUIL-3) AND RECOMBINANT HUMAN MACROPHAGE-COLONY-STIMULATING FACTOR (RHUM-CSF)
Cj. Kovacs et al., STEM-CELL RESPONSES IN MYELOSUPPRESSED MICE FOLLOWING SEQUENTIAL TREATMENT WITH RECOMBINANT HUMAN INTERLEUKIN-1 (RHUIL-1), RECOMBINANT MURINE INTERLEUKIN-3 (RMUIL-3) AND RECOMBINANT HUMAN MACROPHAGE-COLONY-STIMULATING FACTOR (RHUM-CSF), Stem cells, 12(1), 1994, pp. 103-113
In vivo, recombinant human interleukin 1 alpha (rHuIL-1 alpha) + recom
binant human macrophage felony-stimulating factor (rHuM-CSF) (IL-1 + M
-CSF) effectively serves as a rescue agent for myelosuppression by enh
ancing the recovery of hematopoietic stem cell (HSC) subpopulations fo
llowing treatment with 5-fluorouracil (5-mT). Because in vitro studies
have suggested that hematopoietic recovery in 5-FU-treated bone marro
w (FUBM) may proceed from a 5-FU resistant, (IL-1 + IL-3 + M-CSF-respo
nsive) high proliferative potential HSC subpopulation of colony formin
g cells (HCPP-CFC), studies were carried out to determine whether the
addition of recombinant murine interleukin 3 (rMuIL-3) (IL-3) to eithe
r IL-1 or IL-1+ M-CSF would further enhance the recovery of HSC subpop
ulations in myelosuppressed C57B1/6 mice. With the exception of the HP
P-CFC, IL-3 dampened, rather than enhanced, the accelerated recovery o
f 8 d and 12 d colony forming units-spleen (8 d and 12 d CFU-S) and th
e committed macrophage progenitor (CFU-M) associated with in vivo trea
tment with IL-1 alone. Similarly, IL-3 interfered with the enhanced re
covery of those HSC subpopulations in FUBM influenced by the synergist
ic interaction of IL-1+ M-CSF. This interference, however, was observe
d only when the rMuIL-3 was administered on day 2 or 3 of a four-day t
reatment with IL-1 + M-CSF. There was, however, no evidence that IL-3
exerted a negative influence on the restoration of granulocytes in the
myelosuppressed animals. Moreover, sequencing studies provided data s
uggesting that the dampening effects of IL-3 on the synergistic intera
ction of IL-1+ M-CSF resulted from both an enhanced differentiation of
the more primitive HSC subpopulations and a significant, but preferen
tial, mobilization of the more mature 8 d CFU-S and CFU-M to extramedu
llary organs and that the mobilization of these more mature HSC subpop
ulations was temporally linked to their generation from the recovering
HPP-CFC and 12 d CFU-S subpopulations.